Steven Jon  Russell net worth and biography

Steven Russell Biography and Net Worth

Insider of Beta Bionics

Dr. Russell is an endocrinologist and diabetologist with nearly 20 years of experience managing diabetes. He is an Associate Professor of Medicine at Harvard Medical School and an attending physician at the Massachusetts General Hospital (MGH) Diabetes Associates where he maintains a part-time clinical practice managing diabetes in the outpatient and inpatient settings. Dr. Russell’s research has been focused on the application of new technologies to improve the care of people with diabetes, including the collaboration with Dr. Ed Damiano’s research group at Boston University to develop and test a wearable bionic pancreas for automated blood glucose control in diabetes. Dr. Russell has directed nearly all of the bionic pancreas clinical trials, amounting to approximately 20 inpatient and home-use studies in type 1 diabetes, type 2 diabetes and cystic fibrosis related diabetes. He received a Bachelor of Science degree in biochemistry from Trinity University in San Antonio, and both a PhD in biological chemistry and an MD from the University of Texas Southwestern Medical Center. He completed both his residency training in internal medicine and his endocrinology fellowship at MGH, and a postdoctoral fellowship studying insulin and aging at the Joslin Diabetes Center.

What is Steven Jon Russell's net worth?

The estimated net worth of Steven Jon Russell is at least $1.91 million as of December 2nd, 2025. Russell owns 178,071 shares of Beta Bionics stock worth more than $1,909,811 as of March 21st. This net worth estimate does not reflect any other assets that Russell may own. Learn More about Steven Jon Russell's net worth.

How do I contact Steven Jon Russell?

The corporate mailing address for Russell and other Beta Bionics executives is 11 HUGHES, IRVINE, CA, 92618. Beta Bionics can also be reached via phone at (949) 427-7785 and via email at [email protected]. Learn More on Steven Jon Russell's contact information.

Has Steven Jon Russell been buying or selling shares of Beta Bionics?

During the last quarter, Steven Jon Russell has sold $12,681.36 in shares of Beta Bionics stock. Most recently, Steven Jon Russell sold 1,026 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $12.36, for a transaction totalling $12,681.36. Following the completion of the sale, the insider now directly owns 179,096 shares of the company's stock, valued at $2,213,626.56. Learn More on Steven Jon Russell's trading history.

Who are Beta Bionics' active insiders?

Beta Bionics' insider roster includes Stephen Feider (CFO), Mark Hopman (Insider), Mike Mensinger (Insider), and Steven Russell (Insider). Learn More on Beta Bionics' active insiders.

Are insiders buying or selling shares of Beta Bionics?

In the last twelve months, insiders at the sold shares 31 times. They sold a total of 117,369 shares worth more than $2,608,090.96. The most recent insider tranaction occured on March, 4th when insider Mark Hopman sold 353 shares worth more than $4,084.21. Learn More about insider trades at Beta Bionics.

Information on this page was last updated on 3/4/2026.

Steven Jon Russell Insider Trading History at Beta Bionics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2026Sell1,026$12.36$12,681.36179,096View SEC Filing Icon  
12/2/2025Sell1,025$29.34$30,073.50178,071View SEC Filing Icon  
9/2/2025Sell1,015$18.86$19,142.9071,017View SEC Filing Icon  
6/2/2025Sell1,039$17.89$18,587.7172,032View SEC Filing Icon  
See Full Table

Steven Jon Russell Buying and Selling Activity at Beta Bionics

This chart shows Steven Jon Russell's buying and selling at Beta Bionics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Beta Bionics Company Overview

Beta Bionics logo
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Read More

Today's Range

Now: $10.73
Low: $10.50
High: $10.93

50 Day Range

MA: $13.70
Low: $10.11
High: $18.50

2 Week Range

Now: $10.73
Low: $8.89
High: $32.71

Volume

1,714,172 shs

Average Volume

1,076,763 shs

Market Capitalization

$475.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

5.6